Staging is a method of grouping patients by the extent of their disease to determine the choice of treatment, predict prognosis, and compare the results of different treatment approaches. The grade and stage of the Non-Hodgkin's Lymphoma determine the treatment plan. There are four types of treatments used in adult Non-Hodgkin's Lymphoma. Treatment options and prognosis for each patient is dependant on the grade of the malignant cells, clinical staging of the disease, the patient's age and previous responsiveness to treatment. Clients with Non-Hodgkin's Lymphoma present underwriting problems.
Insurability is dependent on the grade and stage of the malignancy at the time of diagnosis.